Prevention of excessive vaginal bleeding after vaginal using misoprostol

Not Applicable

Recruiting

• Conditions: Pregnancy and Childbirth; Post Partum Haemorrhage

• Registration Number: PACTR201303000459148
• Lead Sponsor: Makerere University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-11-19
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 2400

Inclusion Criteria

Attending antenatal during study period
Pregnancy 28 weeks of amenorrhae and more
Willing to be visited at home on the third day after baby by research assistant.
Able and willing to give informed consent
Resident within the study district

Exclusion Criteria

Previous caesarian section
Planned caesarian section delivery
Blood pressure more than 140 mm of Hg systolic and 90 mm of Hg diastolic recorded twice at interval 1 hour
Hemoglobin level less than 8 gms%
Multiple pregnancy
Known history of bronchial asthma
Prior enrollment in this study during previous pregnancy
High risk conditions including: diabetes, cardiac ailments, seizures, placenta praevia or anticipated breech delivery.
Absence of fetal heart sounds
History of known drug allergies
Episodes of ante partum bleeding during the current pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
more than 500ml of blood loss after vaginal births;pre-delivery Hemoglobin change

Secondary Outcome Measures

Name	Time	Method
Transfer to health facility or higher health facility;Blood transfusion;Fluid replacement;Surgical Treatment of PPH;maternal Death